A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers.
Saved in:
| Title: | A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers. |
|---|---|
| Authors: | Tinker, Anna V.1,2 ATinker@bccancer.bc.ca, Altman, Alon D.3,4 alon.altman@cancercare.mb.ca, Bernardini, Marcus Q.5,6 Lilian.Gien@sunnybrook.ca, Ghatage, Prafull7,8 prafull.ghatage@albertahealthservices.ca, Gien, Lilian T.6,9, Provencher, Diane10,11 diane.provencher.med@ssss.gouv.qc.ca, Salvador, Shannon12 shannon.salvador@mcgill.ca, Doucette, Sarah13 sarah@impactmedicom.com, Oza, Amit M.6,14 Amit.Oza@uhn.ca |
| Source: | Current Oncology. Jun2022, Vol. 29 Issue 6, p4354-4369. 16p. 2 Diagrams, 2 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11980052 |
|---|---|
| DOI: | 10.3390/curroncol29060348 |
